802 results on '"Budäus, Lars"'
Search Results
2. Impact of the time interval between biopsy and radical prostatectomy on functional outcomes
3. PSA-density, DRE, and PI-RADS 5: potential surrogates for omitting biopsy?
4. Robot-assisted vs open retropubic radical prostatectomy: a propensity score-matched comparative analysis based on 15 years and 18,805 patients
5. Size of lymph-node metastases in prostate cancer patients undergoing radical prostatectomy: implication for imaging and oncologic follow-up of 2705 lymph-node positive patients
6. Patient-reported Outcome Measures and Decision Regret After Prostate-specific Membrane Antigen–targeted Radioguided Surgery for Oligorecurrent Prostate Cancer
7. Prostate-specific membrane antigen radioguided surgery with negative histopathology: an in-depth analysis
8. Komplikationen nach transrektalen und transperinealen Prostatastanzbiopsien – Ergebnisse der ersten randomisiert-kontrollierten Studie: ProBE-PC
9. Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support
10. Regional Versus Systematic Biopsy in Addition to Targeted Biopsy: Results from a Systematic Review and Meta-analysis
11. Histopathological results of radical prostatectomy specimen of men younger than 50 years of age at the time of surgery: possible implications for prostate cancer screening programs?
12. Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)
13. Suitability of conventional systematic vs. MRI-guided targeted biopsy approaches to assess surgical treatment delay for radical prostatectomy
14. Targeted Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy for Quantitative Gleason 4 Grading Prediction in Radical Prostatectomy Specimens: Implications for Active Surveillance Candidate Selection
15. Pan-segmental intraprostatic lesions involving mid-gland and apex of prostate (mid-apical lesions): assessing the true value of extreme apical biopsy cores
16. Surgical and oncological outcomes of salvage radical prostatectomy after focal therapies: a matched-pair analysis.
17. Size and SUVmax define the contribution of nodal metastases to PSA in oligorecurrent prostate cancer.
18. Bimodal imaging: Detection rate of clinically significant prostate cancer is higher in MRI lesions visible to transrectal ultrasound.
19. MP49-11 PSA-DENSITY, DRE, AND PI-RADS 5: POTENTIAL SURROGATES FOR OMITTING PROSTATE BIOPSY?
20. MP37-19 SIZE OF LYMPH-NODE METASTASES IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY: IMPLICATION FOR IMAGING AND ONCOLOGIC FOLLOW-UP OF 2705 LYMPH-NODE POSITIVE PATIENTS
21. Biochemical Response of <0.1 ng/ml Predicts Therapy-free Survival of Prostate Cancer Patients following Prostate-specific Membrane Antigen–targeted Salvage Surgery
22. Adverse In-Hospital Outcomes after Radical Prostatectomy in Leukemia History Patients.
23. Impact of Adherence to Multidisciplinary Recommendations for Adjuvant Treatment in Radical Prostatectomy Patients With High Risk of Recurrence
24. Rectal Swabs for Detecting Multidrug Resistant Bacteria Prior to Transrectal Prostate Fusion Biopsy: A Prospective Evaluation of Risk Factor Screening and Microbiologic Findings
25. Combined systematic versus stand-alone multiparametric MRI-guided targeted fusion biopsy: nomogram prediction of non-organ-confined prostate cancer
26. Automated multiparametric localization of prostate cancer based on B-mode, shear-wave elastography, and contrast-enhanced ultrasound radiomics
27. Communication processes about predictive genetic testing within high-risk breast cancer families: a two-phase study design
28. Antimicrobial Lubricant Did Not Reduce Infection Rate in Transrectal Biopsy Patients in a Large Randomized Trial Due to Low Complication Rates
29. Assessment of Oncological Outcomes After Radical Prostatectomy According to Preoperative and Postoperative Cancer of the Prostate Risk Assessment Scores: Results from a Large, Two-center Experience
30. Stockholm3- (STHLM3-)Modell-MRT – auf dem Weg zu einer multimodalen Prostatakarzinomdiagnostik?
31. Anterior Localization of Prostate Cancer Suspicious Lesions in 1,161 Patients Undergoing Magnetic Resonance Imaging/Ultrasound Fusion Guided Targeted Biopsies
32. Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer
33. Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer
34. Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens
35. Comparison of 11 Active Surveillance Protocols in Contemporary European Men Treated With Radical Prostatectomy
36. Perioperative management of direct oral anticoagulants in patients undergoing radical prostatectomy: results of a prospective assessment
37. A Multi-Institutional Validation of Gleason Score Derived from Tissue Microarray Cores
38. Active Surveillance und die moderne Diagnostik des Prostatatkarzinoms: Multiparametrische MRT, Fusionsbiopsien und neue genetische Biomarker
39. Inverse stage migration patterns in North American patients undergoing local prostate cancer treatment: a contemporary population-based update in light of the 2012 USPSTF recommendations
40. EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate Cancer
41. Comparative analysis of robot-assisted and open approach for PSMA-radioguided surgery in recurrent prostate cancer
42. Re: Elie Kaplan-Marans, Tenny R. Zhang, Jim C. Hu. Differing Recommendations on Prostate Biopsy Approach to Minimize Infections: An Examination of the European Association of Urology and American Urological Association Guidelines. Eur Urol. 2023;84:445–46
43. Prostate-specific membrane antigen radioguided surgery with negative histopathology: an in-depth analysis
44. Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer
45. Local Therapy Improves Survival in Metastatic Prostate Cancer
46. Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression
47. Association between Lymph Node Counts and Oncological Outcomes in Lymph Node Positive Prostate Cancer
48. Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal Therapy
49. Ein neuer Goldstandard der Prostatakarzinomdiagnostik?: Bedeutung der bildgebungsgestützten gezielten Biopsien
50. Obesity paradox in prostate cancer: increased body mass index was associated with decreased risk of metastases after surgery in 13,667 patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.